{"database": "lobbying", "table": "lobbying_activities", "rows": [[1843132, "715ef6ac-3bfa-4c94-9119-fbaa3de3f9b4", "Q2", "WINNING STRATEGIES WASHINGTON", 50796, "CHARLEY'S FUND", 2016, "second_quarter", "MED", "Implementation of the accelerated approval provision of FDASIA as it pertains to treatments applicable for rare, deadly childhood diseases", "HOUSE OF REPRESENTATIVES,SENATE", 10000, null, 0, 0, "2016-07-15T10:56:32.823000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1843132"], "units": {}, "query_ms": 4.06651699449867, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}